CD8A and pancreatic adenocarcinoma: Of note, CD8+ T cells of pancreatic tumor tissues did not show upregulation of PDCD1 and LAG3, which potentially accounts for the current inapplicability of immune checkpoint inhibitors in pancreatic cancer (PAAD) in contrast to other cancer types16.